[go: up one dir, main page]

FI935897L - Pyridopyrimidinderivat deras framstaellning och anvaendning - Google Patents

Pyridopyrimidinderivat deras framstaellning och anvaendning Download PDF

Info

Publication number
FI935897L
FI935897L FI935897A FI935897A FI935897L FI 935897 L FI935897 L FI 935897L FI 935897 A FI935897 A FI 935897A FI 935897 A FI935897 A FI 935897A FI 935897 L FI935897 L FI 935897L
Authority
FI
Finland
Prior art keywords
preparation
pyridopyrimidine derivatives
pyridopyrimidine
derivatives
Prior art date
Application number
FI935897A
Other languages
English (en)
Finnish (fi)
Other versions
FI935897A7 (sv
FI935897A0 (fi
Inventor
Shuichi Furuya
Tetsuya Ohtaki
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI935897A0 publication Critical patent/FI935897A0/fi
Publication of FI935897A7 publication Critical patent/FI935897A7/sv
Publication of FI935897L publication Critical patent/FI935897L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI935897A 1992-12-29 1993-12-28 Pyridopyrimidinderivat deras framstaellning och anvaendning FI935897L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP36038492 1992-12-29
JP27713693 1993-11-05

Publications (3)

Publication Number Publication Date
FI935897A0 FI935897A0 (fi) 1993-12-28
FI935897A7 FI935897A7 (sv) 1994-06-30
FI935897L true FI935897L (sv) 1994-06-30

Family

ID=26552272

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935897A FI935897L (sv) 1992-12-29 1993-12-28 Pyridopyrimidinderivat deras framstaellning och anvaendning

Country Status (12)

Country Link
US (1) US5654309A (sv)
EP (1) EP0608565B1 (sv)
KR (1) KR940014398A (sv)
CN (1) CN1041090C (sv)
AT (1) ATE214391T1 (sv)
CA (1) CA2112425A1 (sv)
DE (1) DE69331688T2 (sv)
FI (1) FI935897L (sv)
HU (1) HU218782B (sv)
NO (1) NO301762B1 (sv)
RU (1) RU2127734C1 (sv)
TW (1) TW299333B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121724A1 (en) * 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
NZ322197A (en) * 1995-11-21 1999-02-25 Yamanouchi Pharma Co Ltd Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
KR100377787B1 (ko) * 2000-12-29 2003-03-26 씨제이 주식회사 신규한 피리도피리미딘 유도체, 그 제조방법 및 이를포함하는 약제학적 조성물
KR100377788B1 (ko) * 2000-12-29 2003-03-26 씨제이 주식회사 신규한 피리도피리미딘 유도체, 그 제조방법 및 이를포함하는 약제학적 조성물
CN100376571C (zh) * 2001-02-12 2008-03-26 霍夫曼-拉罗奇有限公司 6-取代的吡啶并嘧啶类化合物
DE10110747A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
US6825180B2 (en) 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
RU2225866C1 (ru) * 2002-11-18 2004-03-20 Халиуллин Азат Наилевич Калиевая соль 2-[5(6)-нитро-1-(тиетанил-3)-бензимидазолил-2-тио]уксусной кислоты, проявляющая кардиотоническую активность
GB0230020D0 (en) * 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
CN100506823C (zh) * 2003-12-18 2009-07-01 詹森药业有限公司 作为抗增殖药剂的吡啶并嘧啶和嘧啶并嘧啶衍生物
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
DE102004042607A1 (de) 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituierte Phenylaminothiazole und ihre Verwendung
RU2431484C2 (ru) * 2005-11-10 2011-10-20 Байер Шеринг Фарма Акциенгезельшафт Диарилмочевина для лечения легочной гипертензии
AU2007237874A1 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102006042143A1 (de) 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056740A1 (de) 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102006056739A1 (de) 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102007061763A1 (de) 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102007061764A1 (de) 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE102008013587A1 (de) 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
CA2726020C (en) 2008-05-29 2016-08-16 Bayer Schering Pharma Aktiengesellschaft 2-alkoxy-substituted dicyanopyridines and use thereof
DE102008062567A1 (de) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
EP2266984A1 (en) * 2009-06-26 2010-12-29 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
CN107245074B (zh) * 2017-06-20 2019-04-09 牡丹江医学院附属红旗医院 用于治疗脑梗死的化合物及其制备方法
IL316462A (en) 2022-04-22 2024-12-01 Vertex Pharma Heteroaryl compounds for the treatment of pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275634A (en) * 1965-09-02 1966-09-27 Searle & Co 7-hydroxy-2, 4-dioxo-1, 2, 3, 4, 5, 6-hexahydropyrido[2, 3-d]pyrimidines
JPS5649917B2 (sv) * 1973-12-18 1981-11-25
JPS5758347B2 (sv) * 1974-04-03 1982-12-09 Hisamitsu Pharmaceutical Co
DE3601731A1 (de) * 1986-01-22 1987-07-23 Merck Patent Gmbh Pyrimidinderivate
DE3881467T2 (de) * 1987-10-09 1993-10-21 Agency Ind Science Techn Vasokonstriktor-Peptid.
JPH05509108A (ja) * 1991-01-17 1993-12-16 ファイザー・インコーポレーテッド ２，４−ジオキソ−ピリド［２，３−ｄ］ピリミジン−３−酢酸及びそのエステルと塩
TW270116B (sv) * 1991-04-25 1996-02-11 Hoffmann La Roche

Also Published As

Publication number Publication date
EP0608565A1 (en) 1994-08-03
EP0608565B1 (en) 2002-03-13
FI935897A7 (sv) 1994-06-30
DE69331688T2 (de) 2002-09-12
CA2112425A1 (en) 1994-06-30
ATE214391T1 (de) 2002-03-15
NO934866L (no) 1994-06-30
HU218782B (hu) 2000-12-28
FI935897A0 (fi) 1993-12-28
HU9303774D0 (en) 1994-04-28
KR940014398A (ko) 1994-07-18
NO934866D0 (no) 1993-12-28
US5654309A (en) 1997-08-05
NO301762B1 (no) 1997-12-08
CN1094045A (zh) 1994-10-26
DE69331688D1 (de) 2002-04-18
RU2127734C1 (ru) 1999-03-20
TW299333B (sv) 1997-03-01
HUT66159A (en) 1994-09-28
CN1041090C (zh) 1998-12-09

Similar Documents

Publication Publication Date Title
FI935897L (sv) Pyridopyrimidinderivat deras framstaellning och anvaendning
FI955248A7 (sv) 1-Bifenylmetylimidazolderivat, framställning och terapeutisk användning av dessa
FI955235A7 (sv) Oxazolidindionderivat, deras framställning och användning
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
FI935074A7 (sv) Nya tiopyranopyrrolderivat och framställning av dem
FI940904L (sv) Oxazolidindionderivat, deras framställning och användning
FI943912L (sv) Tienopyrimidinderivat, deras framställning och användning
FI935887L (sv) Tiazolidindionderivat, deras framstaellning och anvaendning
FI940696A7 (sv) Nya pyrazinderivat, deras framställning och användning
FI914611A7 (sv) 2-aminopyrimidin-4-karboxamidderivat, framställning och terapeutisk användning av dem
FI940889A7 (sv) Nya isazinoximderivat, deras preparation och användning
FI941068A7 (sv) Bensoxazinderivat, deras framställning och terapeutisk användning
FI922982A7 (sv) 2-aminopyrimidin-4-karboxamidderivat, framställning av dessa och terapeutisk användning av dessa
FI934680A7 (sv) Arylmorfolin, framställning och använding
FI930716A7 (sv) Nya arylkarbonylaminoalkyldihydrooxopyridiner, framställning och användning av dessa
FI944040A7 (sv) Laktolderivat, deras framställning och användning
FI934221A7 (sv) Piperidinderivat, framställning och terapeutisk användning därav
FI955679A0 (sv) Piperidinderivater, framställning och användning därav
FI920663A7 (sv) Polyhydroxicyklopentanderivat, deras framställning och terapeutiska användning
FI921814A7 (sv) 2-aminopyrimidin-4-karboxiamidderivat, deras framställning och terapeutisk användning av dem
FI970750L (sv) Indol-2,3-dion-oximderivat, framställning och användning av dem
FI941963L (sv) Pyridinderivat, deras framställning och användning
FI935888A7 (sv) 2-amino-6,7-dihydroxi-4-tiaheptansyraderivat, deras framställning och användning
FI922980A7 (sv) 2-piperidinylpyrimidin-4-karboxamidderivat, framställning av dessa ochterapeutisk användning av dessa
FI941214A7 (sv) Bensimidazolderivat, framställning och användning av dessa